SPDS logo

Society for Pharmaceutical Dissolution Science, US Chapter (SPDS-US Chapter) is organizing the Disso America 2024 conference at Rutgers University Campus, Piscataway, NJ.  Disso America 2024 is an in-person conference where we will discuss dissolution challenges related to complex drug products with leading experts from industry and academia. The conference examines the complexity involved in the dissolution/drug release testing of Long-acting injectables and Oral complex dosage forms. The event will occur from June 11-12, 2024, at Rutgers University, Ernst Mario School of Pharmacy, 160 Frelinghuysen Rd, Piscataway, NJ 08854.

Download Agenda (PDF)

Date and time

Tue, Jun 11, 2024, 9:00 AM –

Wed, Jun 12, 2024, 5:00 PM ET



Ernst Mario School of Pharmacy

160 Frelinghuysen Rd

Piscataway, NJ 08854

SPDS US Members($100 off). Please login here.

General: Register here.

Preferred Hotel:

We have a shuttle service from Hyatt Regency, New Brunswick, NJ to Ernst Mario School of Pharmacy.

For a special discounted rate extended to attendees: Book here

Meeting Agenda

Welcome Session | Chair: Sanjay Patel, Merck
Time Title Speaker
09:00 am – 09:05 am Welcome Address Dr. Vinod P. Shah, President, SPDS US Chapter
09:05 am – 09:15 am Keynote Speaker: SPDS and SPDS-US Chapter – Strategies and the Way Forward Dr. Suresh Bhojraj, Pro-Chancellor, JSS Academy of Higher Education
09:15 am – 09:35 am Keynote Speaker: Biorelevant, Bioindicative and Biopredictive Dissolution: Current Perspectives and Future Challenges Prof. Dr. Patrick Sinko, Immediate Past President, AAPS
09:35 am – 10:00 am Long Acting Injectables: Opportunities and Challenges in Product Development Dr. Sujata Sonti, GSK
Session I – Biorelevant / Bio Predictive Models for LAI | Chair: Dr. Sandip Tiwari, BASF
Time Title Speaker
10:00 am – 10:30 am Development of Biorelevant In Vitro Models for the Prediction of Subcutaneous Drug Release and Absorption – What are the Challenges and Where are We? Prof. Dr. Sandra Klein, University of Greifswald
10:30 am – 11:00 am Coffee break
11:00 am – 11:30 am Computational Biopharmaceutics: Exploring the Drug Delivery Lifecycle of Complex Injectables Prof. Dr. Matthias G. Wacker, National University of Singapore
11:30 am – 12:00 am Bio-predictive, Accelerated Release Testing of Single Agent and Combination LAIs Dr. Kruthika Harish Jain, Gilead
12:00 pm – 12:30 pm Panel Discussion. Questions & Answers.
12:30 pm – 02:00 pm Lunch break
Session II – Leading Edge Formulations and In Vitro Techniques for LAI | Chair: Vivek Shah, Sotax
Time Title Speaker
02:00 pm – 02:30 pm The Next Frontier in Pharma: AI and Robotics-Driven Drug Formulation Prof. Dr. Christine Allen, University of Toronto
02:30 pm – 03:00 pm Real-time Release and Accelerated Dissolution of an Implant Dr. Maureen Marsales, Merck and Dr. Hyunho Kang, Merck
03:00 pm – 03:30 pm Coffee Break
03:30 pm – 04:00 pm In Vitro Release Testing for Liposomal Formulations: Challenges and Key Considerations Prof. Dr. Nikoletta Fotaki, University of Bath
04:00 pm – 04:30 pm Prolonged Release Single Does Antimalarial Injection of an ACT Combination Prof. Dr. Padma V. Devarajan, Institute of Chemical Technology
04:30 pm – 05:00 pm In Vitro Release Test for Complex Drug Products: Thinking Outside the Box Dr. Xiaoming Xu, FDA
05:00 pm – 05:30 pm Panel Discussion. Questions & Answers.
05:30 pm – 06:30 pm Wine & Cheese
Session III: Lipid Based Formulations – Session Chair: Dr. Deanna Mudie, Simulations Plus
Time Title Speaker
09:00 am – 09:30 am Roles of In-Vitro Tools for Elucidating Product Performance of Complex Oral Drug Products and their Relationship with Dissolution Testing Dr. Ju (Rob) Tzuchi, AbbVie
09:30 am – 10:00 am Developing SNEDDS for Improving Peptide Oral Delivery Prof. Dr. Annette Mullertz, University of Copenhagen
10:00 am – 10:30 am Innovative Soft Gel Technologies for Modulated Drug Release and Overcoming Challenges in Dissolution Method Development Dr. Karunakar (Karu) Sukuru, Catalent
10:30 am – 11:00 am Coffee Break
11:00 am – 11:30 am Annealing Effects on Dissolution of Oral Lipid Multi-particulates for Controlled Release Dr. Mika Mast, Lonza
11:30 am – 12:00 pm Dissolution Testing of Lipid Based Formulations Dr. Sanjay Jain, Amneal
12:00 pm – 12:30 pm Panel Discussion. Questions & Answers.
12:30 pm – 02:00 pm Lunch break
Session IV: Amorphous Solid Dispersion – Chair: Dr. Xujin Lu, SPDS-US
Time Title Speaker
02:00 pm – 02:30 pm Non-Sink Dissolution Conditions for Predicting Product Quality Dr. Andre Hermans, Merck
02:30 pm – 03:00 pm Elucidating Product Performance of Erosion-Based Dosage Forms through Assessment of Excipient-Functionality in a Non-Sink Environment and Evolution of 3-Dimensional Structure Dr. Ricardo Sosa, AbbVie
03:00 pm – 03:30 pm Coffee Break
03:30 pm – 04:00 pm Crystallization Inhibitors in ASD and Supersaturated Systems Dr. Sandip Tiwari, BASF
04:00 pm – 04:30 pm Complex Oral Formulations and Dissolution Testing: FDA’s Regulatory Perspective Dr. Payal Agarwal, FDA
04:30 pm – 05:00 pm Panel Discussion. Questions & Answers.